Drug Shortage Report for KADIAN
| Report ID | 103865 |
| Drug Identification Number | 02184451 |
| Brand name | KADIAN |
| Common or Proper name | MORPHINE SULFATE |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | MORPHINE SULFATE |
| Strength(s) | 100MG |
| Dosage form(s) | CAPSULE (SUSTAINED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 50BT |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2020-03-15 |
| Actual start date | |
| Estimated end date | 2020-04-01 |
| Actual end date | 2020-03-03 |
| Shortage status | Avoided shortage |
| Updated date | 2020-03-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2020-03-03 | French | Compare |
| v5 | 2020-03-03 | English | Compare |
| v4 | 2020-02-12 | French | Compare |
| v3 | 2020-02-12 | English | Compare |
| v2 | 2020-01-21 | French | Compare |
| v1 | 2020-01-21 | English | Compare |
Showing 1 to 6 of 6